Triple-negative breast cancer (TNBC), closely related to basal-like breast cancer (BLBC), is characterized by an absence of estrogen receptor (ER) and progesterone receptor (PR) expression and a lack of human epidermal growth factor receptor 2 (HER2) overexpression/amplification. This evidence concerns the gene PGR and triple-negative breast carcinoma.